Pluri (PLUR) Cash from Operations Growth (5y) (2015 - 2025)
Pluri (PLUR) Cash from Operations Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Pluri |
21.85 Mn |
22.34 Mn |
86,000.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
7.87% |
| Sep 30, 2025 |
2.44% |
| Jun 30, 2025 |
3.77% |
| Mar 31, 2025 |
7.93% |
| Dec 31, 2024 |
5.99% |
| Sep 30, 2024 |
10.91% |
| Jun 30, 2024 |
8.36% |
| Mar 31, 2024 |
6.90% |
| Dec 31, 2023 |
15.08% |
| Sep 30, 2023 |
7.20% |
| Jun 30, 2023 |
12.92% |
| Mar 31, 2023 |
-1.72% |
| Dec 31, 2022 |
-5.40% |
| Sep 30, 2022 |
-7.95% |
| Jun 30, 2022 |
-5.69% |
| Mar 31, 2022 |
-11.28% |
| Dec 31, 2021 |
-11.30% |
| Sep 30, 2021 |
-17.51% |
| Jun 30, 2021 |
-11.60% |
| Mar 31, 2021 |
-5.57% |
